期刊文献+

高敏C反应蛋白对动脉硬化及心血管事件的早期诊断意义 被引量:6

下载PDF
导出
摘要 目的探讨高敏C反应蛋白(Hs-CRP)对动脉硬化及心血管事件发生的早期诊断意义。方法 75名动脉硬化患者根据Hs-CRP基线四分位值将其分为4组,比较其空腹血浆Hs-CRP、TC、LDL-C、HDL-C、TG、血糖、临床一般情况及初次就诊和6、12、18、24个月复查时的颈动脉内中膜厚度。结果 BMI、吸烟、收缩期高血压、他汀类药物和2型糖尿病均与Hs-CRP相关(P<0.05),尤以2型糖尿病最明显(r=0.57)。多重线性回归分析模型显示,BMI、吸烟、收缩期高血压、他汀类药物、2型糖尿病和Hs-CRP均与CIMT有关(P<0.01),尤其是Hs-CRP最明显(β=0.57)。24个月随访期间,第4区组CIMT增长最明显。结论 Hs-CRP有独立的动脉硬化和心血管事件预测价值。
出处 《广东医学院学报》 2012年第5期507-509,共3页 Journal of Guangdong Medical College
  • 相关文献

参考文献11

  • 1Libby P, Ridker P M, Maseri A. Inflammation and athero- sclerosis[J]. Circulation, 2002, 105(9): 1135-1143.
  • 2Tanne D, Benderly M, Goldbourt U, et al. C-reactive protein as a predictor of incident ischemic stroke among patientswith preexisting cardiovascular disease[J]. Stroke, 2006, 7(37): 1720-1724.
  • 3Devaraj S, Xu D Y, Jialal I. C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endo-thelial cells: implications for the metabolic syndrome and athero-thrombosis [J]. Circulation, 2003, 107(3):398-404.
  • 4Winbeck K, Kukla C, Poppert H, et al. Elevated C-reactive protein is associated with an increased intima to media thickness of the common carotid artery[J]. Cerebrovasc Dis, 2002,13(1):57-63.
  • 5Magyar M T, Szikszai Z, Balla J, et al. Early-onset carotid athero-sclerosis is associated with increased intima-media thickness and elevated serum levels of inflammatory markers[J]. Stroke, 2003, 34(1):58-63.
  • 6Ridker P M, Hennekens C H, Buring J E, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women[J]. N Engl J Med, 2000, 342(12):836-843.
  • 7Lorenz M W, Karbstein P, Markus H S, et al. High-sensitivity C-reactive protein is not associated with carotid intima- media progres-sion: the carotid atherosclerosis progression study[J]. Stroke, 2007, 38(6): 1774-1779.
  • 8Greenfield J R, Samaras K, Jenkins A B, et al. Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences[J]. Circulation, 2004, 109(24):3022-3028.
  • 9Hasday J D, Bascom R, Costa J J, et al. Bacterial endotoxin is an active component of cigarette smoke[J]. Chest, 1999, 115(3):8298-8235.
  • 10郑东诞,高修仁,李玉杰,曾群英.替米沙坦对高血压病脉压和CRP、TNF-α、IL-6的影响[J].中山大学学报(医学科学版),2008,29(5):586-590. 被引量:9

二级参考文献11

  • 1刘力生.2004年中国高血压防治指南(实用本)[J].中华心血管病杂志,2004,32(12):1060-1064. 被引量:2620
  • 2Safar ME, London GM, Asmar R, et al. Recent advances on large arteries in hypertension [J]. Hypertension, 1998,32 (3) : 570-574.
  • 3Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease. Application to clinical and public health practice:A statement for healthcare professionals from the Centers for Disease Control and prevention and the American Heart Association [ J ]. Circulation, 2003,107 ( 3 ) : 499-511.
  • 4Fliser D, Buchholz K, Haller H, et al. Antiinflammatory effects of Angiotensin Ⅱ subtypel receptor blockade in hypertensive patients with microinflammation [J]. Circulation, 2004, 110(9) : 1103-1107.
  • 5Virdis A, Ghiadoni L, Plantinga Y, et al. C-reactive protein and hypertension: is there a causal relationship? [J].Curr Pharm Des, 2007,13(16):1693-1698.
  • 6Kim JS, Kang TS, Kim JB, et al. Significant association of C-reactive protein with arterial stiffness in treated non-diabetic hypertensive patients[J]. Atherosclerosis, 2007,192(2) :401-406.
  • 7Ross R. Atherosclerosis: an inflammatory disease [J]. N Engl J Med, 1999, 340(2): 115-126.
  • 8Pannier BM, Guerin AP, Marchais SJ, et al. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta- blocker in essential hypertension [J]. Clin Exp Pharmacol Physiol, 2001, 28(12) : 1074-1077.
  • 9Ferrario CM, Strawn WB. Role of the rennin-angiotensin- aldosterone system and proinflammatory mediators in cardiovascular disease [J]. Am J Cardiol, 2006,98 ( 1 ) : 121-128.
  • 10Hsueh WA, Bruemmer D. Peroxisome Proliferator- Activated Receptor gamma: Implications for cardiovascular Disease[J]. Hypertension, 2004, 43(2): 297-305.

共引文献8

同被引文献39

  • 1徐彤彤,于方.冠心病患者血清C反应蛋白水平的变化及其临床意义[J].心脏杂志,2004,16(5):443-445. 被引量:7
  • 2付海霞,张嘉莹,赵子牛,李庚山.白细胞介素-6基因多态性及血清水平与原发性高血压的关系[J].第三军医大学学报,2007,29(18):1797-1800. 被引量:7
  • 3Thayapran N, Prigent F, Steingart R, et al. ls there a release of cardiac troponin during exercise testing(alstract)[J]. Circulation, 1997, 96 (Suppl): 1461.
  • 4Muzzio M L, Miksztowicz V, Brites F, et al. Metalloproteases 2 and 9, Lp-PLA(2) and lipoprotein profile in coronary patients[J]. Arch Med Res, 2009, 40(1):48-53.
  • 5Blake G J, Ridker P M. C-reactive protein and other inflammatory risk markers in acute coronary syndromes[J]. J Am Coil Cardiol, 2003 41 (4 Suppl S):37S-42S.
  • 6Hartmann M, von Birgelen C, Mintz G S, et al. Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries [J]. JAm Coil Cardiol, 2006, 48(3): 446-452.
  • 7Verma S, Kuliszewski M A, Li S H, et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease.[J]. Circulation, 2004, 109(17): 2058-2067.
  • 8Laaksonen D E, Niskanen L, Nyyssnen K, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men[J]. Diabetologia, 2004, 47(8): 1403-1410.
  • 9Jtmjun W, Dongmei N, Yang M, et al. Plasma oxidized lipo- protein(a) and its immune complexes are present in newborns and children[J]. Clin Chim Acta, 2009, 407(1-2): 1-5.
  • 10Yagi S, Takashima A, Mitsugi M, et al. Effect of combination tablets containing amlodipine 10 mg and irbesartan 100 mg on blood pressure and cardiovascular risk factors in patients with hypertension[J]. Ther Clin Risk Manag, 2015, 12(11): 83-88.

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部